Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003… Mar 29, 2022
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its “Microdosing”… Feb 3, 2022
atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments Jan 27, 2022
Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling… Jan 10, 2022
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases Nov 5, 2021
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin Oct 27, 2021
